Pharmaceutical opioid analgesic (POA) dependence and treatment responses

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Dependence on opioid based pain medication is a rapidly growing health concern in Australia. In the United States more people die each year from misusing pain medication than from using illicit drugs like heroin. Dr Suzanne Nielsen, an emerging expert in pharmaceutical misuse, will undertake essential research to understand the dependence to opioid pain medication in Australia and to develop appropriate treatment responses.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2016

Funding Scheme: Early Career Fellowships

Funding Amount: $390,628.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

buprenorphine | drug efficacy | opioid analgesia | opioid dependence | pain management | substance use disorders